"Cinnarizine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A piperazine derivative having histamine H1-receptor and calcium-channel blocking activity with vasodilating and antiemetic properties but it induces PARKINSONIAN DISORDERS.
| Descriptor ID |
D002936
|
| MeSH Number(s) |
D03.383.606.290
|
| Concept/Terms |
Cinnarizine- Cinnarizine
- Cinarizine
- 1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine
Cinna- Cinna
- Cinnarizin Von Ct
- Von Ct, Cinnarizin
|
Below are MeSH descriptors whose meaning is more general than "Cinnarizine".
Below are MeSH descriptors whose meaning is more specific than "Cinnarizine".
This graph shows the total number of publications written about "Cinnarizine" by people in this website by year, and whether "Cinnarizine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
| 2002 | 2 | 1 | 3 |
| 2003 | 2 | 0 | 2 |
| 2004 | 2 | 0 | 2 |
| 2005 | 2 | 0 | 2 |
| 2006 | 2 | 0 | 2 |
| 2007 | 2 | 0 | 2 |
| 2008 | 2 | 1 | 3 |
| 2009 | 5 | 1 | 6 |
| 2010 | 1 | 0 | 1 |
| 2011 | 2 | 0 | 2 |
| 2012 | 2 | 2 | 4 |
| 2013 | 2 | 0 | 2 |
| 2014 | 3 | 0 | 3 |
| 2015 | 2 | 1 | 3 |
| 2016 | 3 | 1 | 4 |
| 2017 | 2 | 2 | 4 |
| 2018 | 0 | 1 | 1 |
| 2019 | 2 | 1 | 3 |
| 2020 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Cinnarizine" by people in Profiles.
-
Disinfection threatens aquatic ecosystems. Science. 2020 Apr 10; 368(6487):146-147.
-
Comparisons of in vitro Fick's first law, lipolysis, and in vivo rat models for oral absorption on BCS II drugs in SNEDDS. Int J Nanomedicine. 2019; 14:5623-5636.
-
A Proof of Concept for 3D Printing of Solid Lipid-Based Formulations of Poorly Water-Soluble Drugs to Control Formulation Dispersion Kinetics. Pharm Res. 2019 May 16; 36(7):102.
-
Formulation of Cinnarizine for Stabilization of Its Physiologically Generated Supersaturation. AAPS PharmSciTech. 2019 Mar 11; 20(3):139.
-
Cascade Ligand- and Structure-Based Virtual Screening to Identify New Trypanocidal Compounds Inhibiting Putrescine Uptake. Front Cell Infect Microbiol. 2018; 8:173.
-
Understanding the generation and maintenance of supersaturation during the dissolution of amorphous solid dispersions using modulated DSC and 1H NMR. Int J Pharm. 2018 Jan 30; 536(1):414-425.
-
Management of Sea Sickness in Susceptible Flight Crews. Mil Med. 2017 11; 182(11):e1846-e1850.
-
Identification of novel chemotherapeutic strategies for metastatic uveal melanoma. Sci Rep. 2017 03 17; 7:44564.
-
Solidification of cinnarizine self-nanoemulsifying drug delivery systems by fluid bed coating: optimization of the process and formulation variables. Pharmazie. 2017 Mar 01; 72(3):143-151.
-
Risk of parkinsonism induced by flunarizine or cinnarizine: a population-based study. Eur J Clin Pharmacol. 2017 Mar; 73(3):365-371.